Home FDA labels 48eae225-e9e6-201c-e063-6294a90a67b2 Furosemide openFDA label record# Cross-check layer: This is openFDA JSON-derived label data. Use the corresponding DailyMed SPL as the canonical label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name Furosemide
Generic name FUROSEMIDE
Manufacturer Northwind Health Company, LLC
Product type HUMAN PRESCRIPTION DRUG
SPL set ID f2b920b2-f8b3-1e6e-e053-2a95a90ae153
SPL ID 48eae225-e9e6-201c-e063-6294a90a67b2
Version 2
Effective date 2026-01-01
Source export date 2026-08-01
Source partition 4
Source file https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-08-01/f23e8214fa581dc87bce024b3f15739356a8bb6f9298e3d6be38c21c662a4211/drug-label-0004-of-0014.json.zip
Source manifest SHA-256 bdd1454d0606b622b70458a306b8a10d8a8787db06fd9f46e69c7f7a4524b630
Import run 20260801T225920Z
Imported at 2026-08-01 23:07:30 Harmonized routes table Harmonized routes ORAL
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 12 matching rows.
Warnings cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 2 matching rows.
warnings WARNING Furosemide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required and dose and dose schedule must be adjusted to the individual patient's needs (see DOSAGE AND ADMINISTRATION ).
warnings WARNINGS In patients with hepatic cirrhosis and ascites, furosemide therapy is best initiated in the hospital. In hepatic coma and in states of electrolyte depletion, therapy should not be instituted until the basic condition is improved. Sudden alterations of fluid and electrolyte balance in patients with cirrhosis may precipitate hepatic coma; therefore, strict observation is necessary during the period of diuresis. Supplemental potassium chloride and, if required, an aldosterone antagonist are helpful in preventing hypokalemia and metabolic alkalosis. If increasing azotemia and oliguria occur during treatment of severe progressive renal disease, furosemide should be discontinued. Cases of tinnitus and reversible or irreversible hearing impairment and deafness have been reported. Reports usually indicate that furosemide ototoxicity is associated with rapid injection, severe renal impairment, the use of higher than recommended doses, hypoproteinemia or concomitant therapy with aminoglycoside antibiotics, ethacrynic acid, or other ototoxic drugs. If the physician elects to use high dose parenteral therapy, controlled intravenous infusion is advisable (for adults, an infusion rate not exceeding 4 mg furosemide per minute has been used) (see PRECAUTIONS: Drug Interactions ).
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 2 · 7 matching rows.
adverse reactions ADVERSE REACTIONS Adverse reactions are categorized below by organ system and listed by decreasing severity. Gastrointestinal System Reactions 1. hepatic encephalopathy in patients with hepatocellular insufficiency 6. oral and gastric irritation 7. cramping 2. pancreatitis 8. diarrhea 3. jaundice (intrahepatic cholestatic jaundice) 9. constipation 4. increased liver enzymes 10. nausea 5. anorexia 11. vomiting Systemic Hypersensitivity Reactions 1. severe anaphylactic or anaphylactoid reactions (e.g., with shock) 3. interstitial nephritis 2. systemic vasculitis 4. necrotizing angiitis Central Nervous System Reactions 1. tinnitus and hearing loss 5. headache 2. paresthesias 6. blurred vision 3. vertigo 7. xanthopsia 4. dizziness Hematologic Reactions 1. aplastic anemia 5. leukopenia 2. thrombocytopenia 6. anemia 3. agranulocytosis 7. eosinophilia 4. hemolytic anemia Dermatologic-Hypersensitivity Reactions 1. toxic epidermal necrolysis 7. bullous pemphigoid 2. Stevens-Johnson Syndrome 8. purpura 3. erythema multiforme 9. fever 4. drug rash with eosinophilia and systemic symptoms 10. rash 5. acute generalized exanthematous pustulosis 11. pruritus 6. exfoliative dermatitis 12. urticaria Cardiovascular Reaction Orthostatic hypotension may occur and be aggravated by alcohol, barbiturates or narcotics. Increase in cholesterol and triglyceride serum levels Other Reactions 1. hyperglycemia 6. restlessness 2. glycosuria 7. urinary bladder spasm 3. hyperuricemia 8. thrombophlebitis 4. muscle spasm 9. fever 5. weakness Whenever adverse reactions are moderate or severe, furosemide dosage should be reduced or therapy withdrawn. To report SUSPECTED ADVERSE REACTIONS, contact Solco Healthcare US, LLC at 1-866-257-2597 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
adverse reactions table <table width="100%"><col width="50%"/><col width="50%"/><tbody><tr><td rowspan="2" valign="top"><list listType="ordered"><item>1. hepatic encephalopathy in patients with hepatocellular insufficiency </item></list></td><td valign="top"><list listType="ordered"><item>6. oral and gastric irritation </item></list></td></tr><tr><td valign="top"><list listType="ordered"><item>7. cramping </item></list></td></tr><tr><td valign="top"><paragraph>2. pancreatitis</paragraph></td><td valign="top"><paragraph>8. diarrhea</paragraph></td></tr><tr><td valign="top"><list listType="ordered"><item>3. jaundice (intrahepatic cholestatic jaundice) </item></list></td><td valign="top"><paragraph>9. constipation</paragraph></td></tr><tr><td valign="top"><paragraph>4. increased liver enzymes</paragraph></td><td valign="top"><paragraph>10. nausea</paragraph></td></tr><tr><td valign="top"><paragraph>5. anorexia</paragraph></td><td valign="top"><list listType="ordered"><item>11. vomiting </item></list></td></tr></tbody></table>
adverse reactions table <table width="100%"><col width="50%"/><col width="50%"/><tbody><tr><td valign="top"><list listType="ordered"><item>1. severe anaphylactic or anaphylactoid reactions (e.g., with shock) </item></list></td><td valign="top"><paragraph>3. interstitial nephritis</paragraph></td></tr><tr><td valign="top"><list listType="ordered"><item>2. systemic vasculitis </item></list></td><td valign="top"><paragraph>4. necrotizing angiitis</paragraph></td></tr></tbody></table>
adverse reactions table <table width="100%"><col width="50%"/><col width="50%"/><tbody><tr><td valign="top"><paragraph>1. tinnitus and hearing loss</paragraph></td><td valign="top"><paragraph>5. headache</paragraph></td></tr><tr><td valign="top"><paragraph>2. paresthesias</paragraph></td><td valign="top"><paragraph>6. blurred vision</paragraph></td></tr><tr><td valign="top"><paragraph>3. vertigo</paragraph></td><td valign="top"><paragraph>7. xanthopsia</paragraph></td></tr><tr><td valign="top"><paragraph>4. dizziness</paragraph></td><td valign="top"/></tr></tbody></table>